Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, Quote & AI Analysis

Live DNA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Ginkgo Bioworks Holdings, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Ginkgo Bioworks Holdings, Inc. (DNA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

DNA
Ginkgo Bioworks Holdings, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
8.800000
High
9.369000
Low
8.761200
Volume
882,955
VWAP
-
Market Cap
$543,494,264.43
52W Range
$5.00 - $17.58
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 25, 2026 Q4
After Hours
EPS Estimate: $-1.4746
Revenue Estimate: $37,460,900.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Ginkgo Bioworks Holdings, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Ginkgo Bioworks Holdings, Inc. Overview

Company information

Company Overview

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Company Details
Market Cap
$554.70M
Shares Outstanding
60,590,220
Weighted Shares Outstanding
60,590,219
CEO
Jason Kelly
Address
27 DRYDOCK AVENUE, BOSTON, MA, 02210
Employees
834
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Ginkgo Bioworks Holdings, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...